Appendix I
Contents of Supplement to Volume II
I.1 |
The Prospects for Immunizing Against Brucella abortus |
I.2 |
The Prospects for Immunizing Against Campylobacter |
I.3 |
The Prospects for Immunizing Against Chlamydia spp. |
I.4 |
The Prospects for Immunizing Against Entamoeba histolytica |
I.5 |
The Prospects for Immunizing Against Filaria spp. |
I.6 |
The Prospects for Immunizing Against Giardia lamblia |
I.7 |
The Prospects for Immunizing Against Hantaan Virus |
I.8 |
The Prospects for Immunizing Against Leishmania spp. |
I.9 |
The Prospects for Immunizing Against Measles Virus |
I.10 |
The Prospects for Immunizing Against Measles Virus |
I.11 |
The Prospects for Immunizing Against Mycobacterium tuberculosis |
I.12 |
The Prospects for Immunizing Against Nematodes |
I.13 |
The Prospects for Immunizing Against Qnchocerca volvulus |
I.14 |
The Prospects for Immunizing Against Salmonella Non-Typhi |
I.15 |
The Prospects for Immunizing Against Schistosoma spp. |
I.16 |
The Prospects for Immunizing Against Streptococcus Group B |
I.17 |
The Prospects for Immunizing Against African Trypanosoma spp. |
I.18 |
The Prospects for Immunizing Against South American Trypanosoma spp. |
J |
New Approaches to Vaccine Development |
To be available on a “publication on demand” basis from the National Academy Press.